TY  - CONF

T1  - Radium-223(Ra-223) safety and efficacy in prostate cancer with bone metastases: phase 3 ALSYMPCA study findings stratified by age

JO  - BJU INTERNATIONAL

PY  - 2013/08/01

AU  - Sartor O

AU  - Coleman R

AU  - Nilsson S

AU  - Heinrich D

AU  - Staudacher K

AU  - Garcia-Vargas J

AU  - Vogelzang N

ED  - 

VL  - 112

SP  - 15

EP  - 16

Y2  - 2025/10/10

ER  -